Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2012
03/13/2012US8133485 Immunoglobulin specifi for mast cell immunoglobulin receptor (IRp60) for use in treatment and prevention of allergic disorders
03/13/2012CA2699834C Improved anti-il-6 receptor antibody
03/13/2012CA2489227C Hla-a24-restricted cancer antigen peptides
03/13/2012CA2388709C Gene upregulated in cancers of the prostate
03/13/2012CA2365898C Ibd-associated microbial antigens and methods of using same
03/13/2012CA2356779C Cytokine receptor chain
03/13/2012CA2347649C Mn gene and protein
03/13/2012CA2296272C Mammalian cytokine: interleukin-b30 and related reagents
03/13/2012CA2256308C Antibodies to the ed-b domain of fibronectin, their construction and uses
03/13/2012CA2238080C A novel haemopoietin receptor and genetic sequences encoding same
03/13/2012CA2223716C A method for promoting enzyme diversity
03/13/2012CA2199049C Novel pesticidal proteins and strains
03/13/2012CA2195955C Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
03/08/2012WO2012031260A2 Staphylococcus aureus specific human recombinant polyclonal antibodies and uses thereof
03/08/2012WO2012030982A1 Rapid generation of anti-idiotypic antibodies
03/08/2012WO2012030394A1 Treatment of myocardial infarction using tgf - beta antagonists
03/08/2012WO2012030057A2 Medium composition for culturing self-activated lymphocytes and method for culturing self-activated lymphocytes using same
03/08/2012WO2012029997A1 Influenza virus neutralizing antibody and method for screening same
03/08/2012WO2012029990A1 Antibody against colorectal cancer marker
03/08/2012WO2012029792A1 Compound having activity for inhibiting tgf-β receptor activation, method for screening same, and composition for prevention or treatment of hepatitis c virus-induced diseases
03/08/2012WO2012029694A1 Method for determining whether or not the amino acid in the 100th position of the influenza a virus nucleoprotein is arginine
03/08/2012WO2012029023A1 Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugs
03/08/2012WO2012028958A2 Antibody for colorectal cancer marker
03/08/2012WO2012028716A1 Vegf-binding molecules
03/08/2012WO2012028683A1 Antibody gel system for sustained drug delivery
03/08/2012WO2012027821A1 A trkc receptor agonist antibody to treat neurodegenerative and motor neuron diseases
03/08/2012WO2012007951A8 Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and glutamic acid decarboxylase (gad) autoantigenic peptides
03/08/2012WO2011160859A4 Antibody derivatives
03/08/2012WO2011157741A3 Human antibody drug conjugates against tissue factor
03/08/2012WO2011153300A3 Monoclonal antibodies detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid in plants
03/08/2012WO2011150133A3 Fibronectin based scaffold proteins having improved stability
03/08/2012WO2011136911A3 Anti-erbb3 antibodies
03/08/2012WO2011130603A3 Anti-vla-4 antibodies
03/08/2012WO2011130434A3 Antibodies that bind human cd27 and uses thereof
03/08/2012WO2011130417A3 HUMAN FGF RECEPTOR AND β-KLOTHO BINDING PROTEINS
03/08/2012WO2011130249A3 Methods and compositions for inhibition of treg cells
03/08/2012WO2011109726A9 Homologous multi-specific antibodies
03/08/2012WO2011073954A3 Novel antagonist antibodies and their fab fragments against gpvi and uses thereof
03/08/2012US20120060231 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
03/08/2012US20120059156 Method of protein nanostructure fabrication
03/08/2012US20120059155 Method of Controlling O-Linked Glycosylation of Antibodies
03/08/2012US20120059154 Antigen binding polypeptides
03/08/2012US20120059151 Non-Functional P2X7 Receptor
03/08/2012US20120058907 Mixtures of binding proteins
03/08/2012US20120058572 Antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved
03/08/2012US20120058494 Quenched Dendrimeric Dyes for Florescence Detection
03/08/2012US20120058476 Method Of Oligonucleotide Labeling Using Cycloaddition Reaction
03/08/2012US20120058202 Means and Method for Ovarian Cancer Prognosis
03/08/2012US20120058143 Staphylococcus aureus proteins and nucleic acids
03/08/2012US20120058135 Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
03/08/2012US20120058131 Pta089 protein
03/08/2012US20120058128 Anti- integrin antibodies, compositions, methods and uses
03/08/2012US20120058126 Anti-vegfr-3 antibody compositions
03/08/2012US20120058124 Influenza virus-neutralizing antibody and screening method therefor
03/08/2012US20120058120 Targets for Growth Factor Signalling and Methods of Therapy
03/08/2012US20120058119 Human tumor necrosis factor tr21 and methods based thereon
03/08/2012US20120058118 A-beta binding polypeptides
03/08/2012US20120058117 Neuropilin-1 inhibitors
03/08/2012US20120058111 Sialylated antigen-specific antibodies for treatment or prophylaxis of unwanted inflammatory immune reactions and methods of producing them
03/08/2012US20120058105 Method of treatment of vascular complications
03/08/2012US20120058082 Methods and compositions for treatment
03/08/2012US20120058052 Method for avian sex determination
03/08/2012US20120058051 Anti-human ror1 antibodies
03/08/2012CA2810217A1 Anti-cxcl13 antibodies and methods of using the same
03/08/2012CA2810171A1 Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugs
03/08/2012CA2810030A1 Staphylococcus aureus specific human recombinant polyclonal antibodies and uses thereof
03/08/2012CA2810016A1 Novel modulators and methods of use
03/08/2012CA2809864A1 Identification and enrichment of cell subpopulations
03/08/2012CA2809837A1 Human immunodeficiency virus (hiv)-neutralizing antibodies
03/08/2012CA2809780A1 Influenza virus neutralizing antibody and method for screening same
03/08/2012CA2809677A1 Anti-c-met antibody and methods of use thereof
03/08/2012CA2809568A1 Treatment of myocardial infarction using tgf - beta antagonists
03/08/2012CA2809493A1 Peptide or peptide complex binding to .alpha.2 integrin and methods and uses involving the same
03/08/2012CA2809443A1 Novel antigen binding proteins
03/08/2012CA2808696A1 Vegf-binding molecules
03/07/2012EP2426150A1 Anti-NKG2A antibodies and uses thereof
03/07/2012EP2426149A1 Anti-cadherin antibody
03/07/2012EP2426148A1 Anti-il-3ra antibody for use in treatment of blood tumor
03/07/2012EP2426147A1 Method for producing anti-gpcr antibody and anti-gpcr antibody
03/07/2012EP2426146A2 Anti-human IL-21 monoclonal antibodies
03/07/2012EP2426145A1 Engineered anti-IL-23p19 antibodies
03/07/2012EP2426144A1 Engineered anti-IL-23p19 antibodies
03/07/2012EP2426143A2 Method of providing disease-specific binding molecules and targets
03/07/2012EP2425850A2 Bispecific single chain FV antibody molecules and methods of use thereof
03/07/2012EP2425847A1 Methods of treating cancer using IL-21 and monoclonal antibody therapy
03/07/2012EP2425838A2 Combination therapy for treatment of immune disorders
03/07/2012EP2425259A1 Immunoassay for the detection of procalcitonin
03/07/2012EP2425010A2 Dual variable domain immunoglobulins and uses thereof
03/07/2012EP2425009A1 Improved antibodies immunoreactive with heregulin-coupled her3
03/07/2012EP2425008A1 Toll-like receptor 3 antagonists
03/07/2012EP2424897A1 Anti cxcr4 antibodies for the treatment of hiv
03/07/2012EP2424896A1 Anti ceacam1 antibodies and methods of using same
03/07/2012EP2424895A1 Compositions and methods for increasing muscle growth
03/07/2012EP2424894A1 Composition and methods of use for therapeutic antibodies specific for the il-12 receptore betal subunit
03/07/2012EP2424893A2 Pharmaceutical agent
03/07/2012EP2424892A2 Dc-stamp antibodies
03/07/2012EP2424891A1 Erg monoclonal antibodies
03/07/2012EP2424890A2 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
03/07/2012EP2424889A2 Method for the production of domain antibodies
03/07/2012EP2424884A1 A novel subtype of clostridium botulinum neurotoxin type a and uses thereof
1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 1494